| Financial Year |
March 31 2023 |
| Monetary Funds |
536,122,980.56 |
| Held-for-trading Financial Assets |
57,253,277.78 |
| Notes Receivable |
5,478,687.47 |
| Accounts Receivable |
236,641,214.96 |
| Advances to Suppliers |
25,089,955.46 |
| Other Receivables |
14,224,223.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
235,082,091.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,587,989.23 |
| Total Current Assets |
1,134,953,245.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
49,885,524.90 |
| Under-construction Projects |
46,269,188.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,103,529.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,011,604.08 |
| Deferred Income Tax Assets |
9,822,631.44 |
| Other Non-Current Assets |
7,876,246.27 |
| Sub-Total of Non-Current Assets |
129,968,724.17 |
| Total Assets |
1,264,921,969.76 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
55,811,925.14 |
| Accounts Payable |
121,047,481.12 |
| Accounts Received In Advance |
129,628.74 |
| Employee Compensation Payable |
663,988.15 |
| Taxes Payable |
2,757,348.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
971,919.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,105,344.86 |
| Sub-Total of Current Liabilities |
341,646,177.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
341,646,177.09 |
| Paid-In Capital(Or Share Stock) |
114,040,000.00 |
| Capital Surplus |
569,491,110.12 |
| Surplus Reserve |
17,983,934.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
204,885,488.44 |
| Minority Stockholder's Interest |
16,875,259.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
906,400,532.87 |
| Owner's Equity（Stockholder's Equity） |
923,275,792.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,264,921,969.76 |
